ZENOTECH LABORATORIES
|
ZENOTECH LABORATORIES Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 1.90 | 3.63 | -0.20 | 1.77 | -0.51 |
| CEPS(Rs) | 3.07 | 4.78 | 0.86 | 2.56 | 0.18 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 13.48 | 11.57 | 7.93 | 8.13 | 6.37 |
| Tax Rate(%) | 20.11 | -123.97 | - | - | - |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 48.80 | 47.75 | 28.42 | 34.51 | -26.99 |
| EBIT Margin(%) | 34.45 | 30.40 | 1.48 | 44.85 | -23.10 |
| Pre Tax Margin(%) | 34.18 | 27.08 | -5.41 | 41.42 | -24.00 |
| PAT Margin (%) | 27.31 | 60.65 | -5.41 | 41.42 | -24.00 |
| Cash Profit Margin (%) | 44.22 | 79.72 | 23.35 | 60.06 | 8.25 |
| Performance Ratios | |||||
| ROA(%) | 13.37 | 26.45 | -1.42 | 12.67 | -3.76 |
| ROE(%) | 15.15 | 37.26 | -2.48 | 24.35 | -7.73 |
| ROCE(%) | 18.39 | 15.26 | 0.48 | 18.32 | -5.95 |
| Asset Turnover(x) | 0.49 | 0.44 | 0.26 | 0.31 | 0.16 |
| Sales/Fixed Asset(x) | 0.40 | 0.35 | 0.26 | 0.40 | 0.23 |
| Working Capital/Sales(x) | -123.98 | -4.46 | -2.95 | -0.88 | -0.50 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 2.50 | 2.83 | 3.81 | 2.47 | 4.42 |
| Receivable days | 31.20 | 38.59 | 46.02 | 29.56 | 33.08 |
| Inventory Days | - | 0.61 | 1.27 | 4.76 | 19.68 |
| Payable days | - | - | - | 3,153.54 | 2,423.96 |
| Valuation Parameters | |||||
| PER(x) | 24.79 | 13.86 | - | 8.32 | - |
| PCE(x) | 15.31 | 10.54 | 40.76 | 5.74 | 120.64 |
| Price/Book(x) | 3.49 | 4.35 | 4.41 | 1.81 | 3.33 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 6.51 | 8.50 | 10.33 | 4.12 | 10.49 |
| EV/Core EBITDA(x) | 12.67 | 17.18 | 34.15 | 10.57 | 114.60 |
| EV/EBIT(x) | 18.89 | 27.97 | 697.37 | 9.19 | -45.42 |
| EV/CE(x) | 3.02 | 3.80 | 2.70 | 1.25 | 1.62 |
| M Cap / Sales | 6.77 | 8.40 | 9.52 | 3.45 | 9.95 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 16.02 | 62.91 | -13.74 | 99.71 | 16.91 |
| Core EBITDA Growth(%) | 20.44 | 166.48 | -33.12 | 751.01 | 121.69 |
| EBIT Growth(%) | 31.47 | 3,244.31 | -97.15 | 487.80 | 67.99 |
| PAT Growth(%) | -47.76 | 1,925.03 | -111.27 | 444.66 | 73.61 |
| EPS Growth(%) | -47.76 | 1,925.01 | -111.27 | 444.66 | 73.61 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | 0.08 | 0.43 | 0.38 | 0.52 |
| Current Ratio(x) | 0.98 | 0.47 | 0.49 | 0.16 | 0.42 |
| Quick Ratio(x) | 0.98 | 0.47 | 0.49 | 0.16 | 0.41 |
| Interest Cover(x) | 130.25 | 9.15 | 0.21 | 13.08 | -25.57 |
| Total Debt/Mcap(x) | - | 0.02 | 0.10 | 0.21 | 0.16 |
Compare Financial Ratios of peers of ZENOTECH LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZENOTECH LABORATORIES | ₹395.6 Cr | -6.8% | 3.9% | 19.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
| CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics | |
ZENOTECH LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZENOTECH LABORATORIES | -6.8% |
3.9% |
19.2% |
| SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses
